France's AB Science Wins Patent for Rare Neurological Disease Dr
Updated
France's AB Science Wins Patent for Rare Neurological Disease Drug in Japan
AB Science secured a Japanese patent for its masitinib drug's use in treating amyotrophic lateral sclerosis, a rare neurological condition.
BUY
AB Science secured a Japanese patent for its masitinib drug's use in treating amyotrophic lateral sclerosis, a rare neurological condition.
BUY
Note
SL 4.9
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.